BioMedical Design Novo Nordisk Foundation Fellowship Programme

We empower and launch healthcare innovators

At BioMedical Design Novo Nordisk Foundation Fellowship Programme we train talents to spot needs in the health sector and create solutions which help patients and health professionals in hospitals.

Our fellows learn how to commercialise their solution and establish a start-up. Fellows work in interdisciplinary teams within the fields of design thinking, health innovation, science, business development and entrepreneurship.


10 months – full time.

Study location:

Aarhus or Copenhagen.


All teaching is in English.

We invite 16 talents to join the fellowship each year. 10 fellows will be at each of our office spaces in either Aarhus or Copenhagen. The fellowship is free, and stipend paid. The fellowship is an upgrade to your competencies, and career opportunities lie within health innovation either internally at a hospital or company or as a start-up.

Can you create value for future healthcare?

  • A bachelor degree + min. 5 years of work experience
  • A master degree + min 3 years of work experience (research work and post doc work count as work experience)
  • If you are a medical doctor you need to have completed your KBU and first year of residence.
  • A professional background within medicine, life science, business administration, engineering, design, or social science disciplines.
  • A proven track record from the healthcare sector or industry. Alternatively, documented experience in running innovation projects or entrepreneurial activities.
  • An interest in interdisciplinary work, flexibility on mobility requirements/travel activities, and possibility to get a leave of absence from your job, if you are employed.

About us

We empower and launch healthcare entrepreneurs to create value for future healthcare. Our goal is to inspire talents to become exceptional innovators to impact healthcare through needs-led innovation.

BioMedical Design is a cross institutional initiative at Aarhus University and the University of Copenhagen and funded by the Novo Nordisk Foundation.